BNP Paribas Financial Markets’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.34M Sell
26,326
-46,229
-64% -$13.3M ﹤0.01% 1755
2025
Q4
$22M Buy
72,555
+69,254
+2,098% +$21.6M 0.01% 1118
2025
Q3
$926K Sell
3,301
-536
-14% -$146K ﹤0.01% 3189
2025
Q2
$926K Sell
3,837
-4,615
-55% -$1.09M ﹤0.01% 2959
2025
Q1
$2.06M Buy
8,452
+904
+12% +$272K ﹤0.01% 2349
2024
Q4
$2.48M Sell
7,548
-896
-11% -$304K ﹤0.01% 2248
2024
Q3
$2.83M Sell
8,444
-11,995
-59% -$3.81M ﹤0.01% 1853
2024
Q2
$5.58M Buy
20,439
+11,924
+140% +$3.47M 0.01% 1364
2024
Q1
$2.95M Sell
8,515
-18,410
-68% -$6.05M ﹤0.01% 1814
2023
Q4
$8.69M Buy
26,925
+12,662
+89% +$3.97M 0.02% 1096
2023
Q3
$5.11M Buy
14,263
+521
+4% +$201K 0.01% 1253
2023
Q2
$5.21M Sell
13,742
-4,429
-24% -$1.8M 0.01% 1219
2023
Q1
$8.7M Sell
18,171
-3,185
-15% -$1.49M 0.02% 970
2022
Q4
$8.98M Buy
21,356
+4,240
+25% +$1.71M 0.02% 1019
2022
Q3
$7.14M Buy
17,116
+10,380
+154% +$5.18M 0.02% 1178
2022
Q2
$3.33M Sell
6,736
-9,120
-58% -$4.75M 0.01% 1444
2022
Q1
$8.93M Buy
15,856
+7,935
+100% +$4.78M 0.02% 997
2021
Q4
$5.98M Sell
7,921
-1,873
-19% -$1.4M 0.01% 1236
2021
Q3
$7.31M Sell
9,794
-2,614
-21% -$1.96M 0.02% 1100
2021
Q2
$7.99M Buy
12,408
+11,340
+1,062% +$6.9M 0.02% 1054
2021
Q1
$610K Sell
1,068
-6,766
-86% -$4.01M ﹤0.01% 2455
2020
Q4
$4.57M Sell
7,834
-6,207
-44% -$3.53M 0.02% 1193
2020
Q3
$7.24M Sell
14,041
-6,814
-33% -$3.45M 0.02% 905
2020
Q2
$9.42M Buy
20,855
+12,822
+160% +$5.66M 0.02% 730
2020
Q1
$2.82M Sell
8,033
-13,800
-63% -$5.07M 0.01% 1288
2019
Q4
$8.08M Sell
21,833
-93,350
-81% -$32.9M 0.03% 966
2019
Q3
$38.3M Buy
115,183
+113,568
+7,032% +$37M 0.12% 290
2019
Q2
$505K Sell
1,615
-43,386
-96% -$13M ﹤0.01% 1997
2019
Q1
$13.8M Buy
45,001
+20,304
+82% +$5.48M 0.05% 560
2018
Q4
$5.74M Buy
24,697
+5,644
+30% +$1.51M 0.03% 857
2018
Q3
$5.96M Buy
19,053
+9,640
+102% +$2.99M 0.01% 1065
2018
Q2
$2.72M Buy
9,413
+8,570
+1,017% +$2.37M 0.01% 1364
2018
Q1
$211K Sell
843
-3,286
-80% -$837K ﹤0.01% 2764
2017
Q4
$985K Sell
4,129
-2,422
-37% -$587K ﹤0.01% 1988
2017
Q3
$1.46M Sell
6,551
-1,331
-17% -$300K ﹤0.01% 1318
2017
Q2
$1.78M Buy
7,882
+3,047
+63% +$664K 0.01% 1240
2017
Q1
$964K Sell
4,835
-1,452
-23% -$280K ﹤0.01% 1377
2016
Q4
$1.15M Buy
6,287
+4,016
+177% +$685K 0.01% 1236
2016
Q3
$372K Sell
2,271
-28,170
-93% -$4.28M ﹤0.01% 1387
2016
Q2
$4.35M Sell
30,441
-72,181
-70% -$10.3M 0.02% 522
2016
Q1
$14M Buy
102,622
+99,264
+2,956% +$13M 0.06% 271
2015
Q4
$466K Sell
3,358
-276,558
-99% -$38.3M ﹤0.01% 1405
2015
Q3
$37.6M Buy
279,916
+276,202
+7,437% +$39.8M 0.09% 137
2015
Q2
$559K Sell
3,714
-1,015
-21% -$145K ﹤0.01% 1314
2015
Q1
$639K Buy
4,729
+4,310
+1,029% +$534K ﹤0.01% 1229
2014
Q4
$50.5K Sell
419
-4,551
-92% -$524K ﹤0.01% 1686
2014
Q3
$564K Buy
4,970
+1,232
+33% +$146K ﹤0.01% 1478
2014
Q2
$447K Sell
3,738
-570
-13% -$69.6K ﹤0.01% 1532
2014
Q1
$531K Buy
4,308
+3,932
+1,046% +$504K ﹤0.01% 1404
2013
Q4
$46.5K Buy
+376
New +$45.8K ﹤0.01% 1943

Other funds holding BIO